MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patients
Article 2002 en
Authors
MS
Maria Pia Sormani
PB
Paolo Bruzzi
GC
Gıancarlo Comı
Abstract
1 min read
This preliminary study suggests that conventional MRI metrics might serve as valid surrogate endpoints in MS trials with glatiramer acetate or treatments thought to have a similar mode of action.
Atthanee Jeeyapant, Hugh W. F. Kingston, Katherine Plewes, Richard J. Maude, Josh Hanson, Michael Herdman, Stije J. Leopold, Thatsanun Ngernseng, Prakaykaew Charunwatthana, Nguyen Hoan Phu, Aniruddha Ghose, Md Mahtab Uddin Hasan, Caterina Fanello, Md Abul Faiz, Tran Tinh Hien, Nicholas Day, Sir Nicholas White, Arjen M. Dondorp
Discussion(0)
No comments yet. Be the first to comment.